BMY vs LZB · P/E 17, rev $24.46B vs P/E 17, rev $2.13B
Bristol-Myers Squibb Company (BMY) versus La-Z-Boy Incorporated (LZB) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
La-Z-Boy Incorporated (LZB) is a furnishings, fixtures & appliances company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LZB revenue for 2026-04-25 was $2.13B. Net income was $102.0M. Revenue was up 0.8% from 2025-04-26 to 2026-04-25. LZB currently screens at market cap $1.62B and trailing P/E 16.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LZB currently screens at market cap $1.62B and trailing P/E 16.8.
Not investment advice. Open the BMY and LZB stock pages for the full models.
Not investment advice.